Facebook Inc (NASDAQ:FB) has simplified and shortened its privacy policy by more than two thirds in hopes of getting its 1.35 billion users to read and understand how it targets advertisements to them. Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 24.50% and weekly performance is -1.34%. On last trading day company shares ended up $74.25. Facebook Inc (NASDAQ:FB) distance from 50-day simple moving average (SMA50) is -3.08%. On Nov. 11, Cellectar Biosciences, Inc. (NASDAQ:CLRB) said it is providing an overview of its development programs and financial results for the third quarter 2014. Publication detailing efficacy of Cellectar's proprietary phospholipid ether (PLE) analog agents for the detection, imaging and real-time visualization of colorectal cancer was published in PLOS ONE, an international, peer-reviewed publication. Cellectar Biosciences, Inc. (NASDAQ:CLRB) shares decreased -0.34% in last trading session and ended the day at $2.91. CLRB return on assets is -134.70%. Cellectar Biosciences, Inc. (NASDAQ:CLRB) quarterly performance is -9.06%. On Nov. 10, Nabors Industries Ltd. (NYSE:NBR) reported revised third-quarter 2014 diluted earnings per share from continuing operations of $0.34, versus the $0.19 previously announced in our earnings press release for the third quarter of 2014 that was issued on October 21, 2014. The revision is due to a change in the non-cash income tax provision for the third quarter. On 13 November, Nabors Industries Ltd. (NYSE:NBR) shares decreased -3.60% and was closed at $16.62. NBR EPS growth in last 5 year was -22.20%. Nabors Industries Ltd. (NYSE:NBR) year to date (YTD) performance is -1.66%. On Oct 31, Vantage Drilling Company (NYSEMKT:VTG) reports net income for the three months ended September 30, 2014 of $751,000 or $0.00 per diluted share, excluding gains for the early retirement of debt and an upward revision to the tax provision, as compared to earnings of $6.8 million or $0.02 per diluted share for the three months ended September 30, 2013. Including approximately $1.1 million gain on the early retirement of debt and a $7.4 million revision to the tax provision for the three months ended September 30, 2014, the Company reported a net loss of $5.6 million or ($0.02) per diluted share. Vantage Drilling Company (NYSEMKT:VTG) ended the last trading day at $0.89. Company weekly volatility is calculated as 7.00% and price to cash ratio as 3.38. Vantage Drilling Company (NYSEMKT:VTG) showed a weekly performance of -3.83%. On Nov. 6, Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) announced that Scott Jackson, Chief Executive Officer, will present an overview of the company at the Stifel 2014 Healthcare Conference on November 19, 2014 at 4:10 p.m. ET in New York City. Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) shares increased 3.96% in last trading session and ended the day at $2.10. CPXX return on assets is -59.40%. Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) quarterly performance is -23.64%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
